Earnings Preview: ENDRA Life Sciences
Portfolio Pulse from Benzinga Insights
ENDRA Life Sciences (NASDAQ:NDRA) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.43. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, NDRA's stock price has been volatile post-earnings, with a mix of positive and negative reactions. The stock is currently trading at $0.954, down 76.92% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
November 13, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ENDRA Life Sciences is set to report earnings with an anticipated EPS of $-0.43. Historical data shows significant stock price movement post-earnings, and long-term shareholders are currently bearish.
The score is neutral (0) because while an earnings beat could positively influence the stock, historical performance indicates mixed reactions post-earnings. The relevance is 100 as the news is directly about NDRA's earnings. The importance is high (90) due to the potential for significant stock movement post-earnings, but not 100 because the stock has already been on a downward trend. Confidence is at 80, acknowledging the unpredictable nature of market reactions to earnings reports.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100